(Q41026178)

25 September 2017

Efficacy and safety of long-term fluoxetine treatment of obesity--maximizing success (English)

1 reference

25 September 2017

1 reference

Goldstein DJ

1

1 reference

25 September 2017

Rampey AH Jr

2

1 reference

25 September 2017

Roback PJ

3

1 reference

25 September 2017

Wilson MG

4

1 reference

25 September 2017

Hamilton SH

5

1 reference

25 September 2017

Sayler ME

6

1 reference

25 September 2017

Tollefson GD

7

1 reference

25 September 2017

1 November 1995

1 reference

25 September 2017

1 reference

25 September 2017

3 Suppl 4

1 reference

25 September 2017

481S-490S

1 reference

Proposed standards for judging the success of the treatment of obesity

25 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00216.X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00216.X

Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotoninergic inhibition of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00216.X

Estimation of a common effect parameter from sparse follow-up data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00216.X

International trial of long-term dexfenfluramine in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00216.X

Baseline predictors of success when comparing two treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00216.X

Health implications of overweight and obesity in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00216.X

Long-term weight control: the National Heart, Lung, and Blood Institute funded multimodal intervention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00216.X

Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00216.X

Behavioral strategies for weight reduction in obese type II diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00216.X

Fenfluramine and fluoxetine spare protein consumption while suppressing caloric intake by rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1995.TB00216.X

10.1002/J.1550-8528.1995.TB00216.X

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference